Posts Tagged: "Harvard"

Patenting activities in the quantum computing sector have rapidly increased in recent years, with the U.S. by far the preferred jurisdiction for applicants… One interesting finding from the Patinformatics report is that, although Northrop Grumman doesn’t have the largest portfolio in the field, it is well-situated to compete with the biggest players. “One of our main assertions is that, if there’s an organization interested in being competitive with IBM, they may want to contemplate a partnership or acquisition of Northrop Grumman,” Trippe said. Both Northrop and IBM have made significant investments into super-conducting loop qubit technologies and Northrop actually edges IBM in logic gate hardware.

I was just thinking how often someone teaching intellectual property law leads the attack on the patent system when “Racing for academic glory and patents: Lessons from CRISPR” appeared. It sounds a dire warning that “overly broad patents must be reined in” as the passage of the Bayh-Dole Act “invoking patents as a mechanism for promoting commercialization of federally funded research” set off an “often socially wasteful race…for glory in academic research and in the patent sphere.” What’s particularly striking is that neither the paper nor the articles hyping it provide any evidence the CRISPR patents are restricting research or blocking commercial development. Indeed, most signs point in the opposite direction… Doesn’t a finding by NIH that there’s no evidence of any problems with how universities are licensing their CRISPR patents deserve to be mentioned? It seems like a pretty important point.

Arguing against Micron’s motion to dismiss, Harvard contended that TC Heartland only affirmed a previous precedent set by SCOTUS and that the improper venue challenge was available to Micron back when it filed its first motion in August 2016… The Federal Circuit concluded that the TC Heartland decision “changed controlling law in the relevant sense” and thus the Supreme Court’s interpretation of the patent venue statute was not available to Micron at the time of its August 2016 motion to dismiss.concluded that the TC Heartland decision “changed controlling law in the relevant sense” and thus the Supreme Court’s interpretation of the patent venue statute was not available to Micron at the time of its August 2016 motion to dismiss.

Most fields of chemical science designed to look at biological process involving living molecules suffer from a rather serious drawback— studying those molecules within a living body without interfering with any other processes. Over the past two decades, however, an entirely new scientific field has opened up which enables the study of chemical reactions occurring within living systems with no interference to any biochemical processes native to that living system. Bioorthogonal chemistry was pioneered by Dr. Carolyn Bertozzi, a 2017 inductee into the National Inventors Hall of Fame. This Thursday, October 5th, is the seventh anniversary of the date of issue of the patent for which Bertozzi has been inducted. As we often do, we’ll return to our Evolution of Tech series to see how this particular innovation was developed and how it helped to unlock a completely new field of scientific research.